TY - JOUR
T1 - Nasal decolonization
T2 - What antimicrobials are most effective prior to surgery?
AU - Septimus, Edward J.
N1 - Publisher Copyright:
© 2019 Association for Professionals in Infection Control and Epidemiology, Inc.
PY - 2019/6
Y1 - 2019/6
N2 - Background: Surgical site infection (SSI)is one of the most common health care–associated infections. Staphylococcus aureus remains the most common etiologic agent causing SSIs. Studies confirm S aureus carriage increases the risk of S aureus SSIs. The purpose of this article is to review the strategies to reduce SSIs due to S aureus focusing on nasal decolonization. Results: Published studies indicate screening patients for S aureus nasal carriage and decolonizing carriers during the preoperative period decreases the risk of S aureus SSIs in cardiac and orthopedic surgery. Mupirocin remains the best topical agent at eradicating nasal S aureus however, concerns over resistance have led to development of alternative agents. Nasal povidone-iodine, alcohol-based nasal antiseptic, and photodynamic therapy are promising new interventions, but more studies are needed. Conclusions: Short term nasal mupirocin is still the most studied and effective topical agent in eradicating S aureus nasal colonization. However, increasing mupirocin resistance remains an ongoing concern and newer agents are needed. Currently, preoperative S aureus decolonization often uses combination chlorhexidine gluconate bathing and nasal mupirocin considering that colonization of multiple body sites is commonly seen.
AB - Background: Surgical site infection (SSI)is one of the most common health care–associated infections. Staphylococcus aureus remains the most common etiologic agent causing SSIs. Studies confirm S aureus carriage increases the risk of S aureus SSIs. The purpose of this article is to review the strategies to reduce SSIs due to S aureus focusing on nasal decolonization. Results: Published studies indicate screening patients for S aureus nasal carriage and decolonizing carriers during the preoperative period decreases the risk of S aureus SSIs in cardiac and orthopedic surgery. Mupirocin remains the best topical agent at eradicating nasal S aureus however, concerns over resistance have led to development of alternative agents. Nasal povidone-iodine, alcohol-based nasal antiseptic, and photodynamic therapy are promising new interventions, but more studies are needed. Conclusions: Short term nasal mupirocin is still the most studied and effective topical agent in eradicating S aureus nasal colonization. However, increasing mupirocin resistance remains an ongoing concern and newer agents are needed. Currently, preoperative S aureus decolonization often uses combination chlorhexidine gluconate bathing and nasal mupirocin considering that colonization of multiple body sites is commonly seen.
KW - Health care–associated infections
KW - Mupirocin
KW - Surgical site infections
UR - http://www.scopus.com/inward/record.url?scp=85063787155&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85063787155&partnerID=8YFLogxK
U2 - 10.1016/j.ajic.2019.02.028
DO - 10.1016/j.ajic.2019.02.028
M3 - Review article
C2 - 31146851
AN - SCOPUS:85063787155
VL - 47
SP - A53-A57
JO - American Journal of Infection Control
JF - American Journal of Infection Control
SN - 0196-6553
ER -